Olympus Medical Systems India Profile
Key Indicators
- Authorised Capital ₹ 82.50 Cr
as on 07-07-2024
- Paid Up Capital ₹ 72.50 Cr
as on 07-07-2024
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 34.79%
(FY 2023)
- Profit 69.86%
(FY 2023)
- Ebitda 32.31%
(FY 2023)
- Net Worth -4.60%
(FY 2023)
- Total Assets 3.87%
(FY 2023)
About Olympus Medical Systems India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 82.50 Cr and a paid-up capital of Rs 72.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Olympus Medical Systems India Private Limited India is Ankita as COMPANY SECRETARY. Shalabh Kapoor, Marc Radatt, and Naoshi Kikumoto serve as directors at the Company.
- CIN/LLPIN
U33110HR2009FTC039611
- Company No.
039611
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
20 Oct 2009
- Date of AGM
10 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurgoan, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Olympus Medical Systems India?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankita  | Company Secretary | 02-Sep-2021 | Current |
| Naoshi Kikumoto | Managing Director | 01-Jul-2019 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Marc Radatt  | Director | 10-Jul-2019 | Current |
| Shalabh Kapoor | Director | 01-Jul-2020 | Current |
Financial Performance of Olympus Medical Systems India.
Olympus Medical Systems India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 34.79% increase. The company also saw a substantial improvement in profitability, with a 69.86% increase in profit. The company's net worth dipped by a decrease of 4.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Olympus Medical Systems India?
In 2023, Olympus Medical Systems India had a promoter holding of 0.05% and a public holding of 99.95%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Olympus Medical Systems India?
Olympus Medical Systems India has a workforce of 540 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Olympus Medical Systems India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Olympus Medical Systems India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
